More from ACS meeting: Pfizer presents potent new leukotriene antagonists with oral activity April 1, 1999
Excellent efficacy reported with topical ciclesonide in patients with allergic rhinitis March 31, 1999
Dual LTD4/TxA2 antagonist demonstrates superior bronchodilating efficacy in animal models March 31, 1999